#Drug Development
11 articles with this tag
AlphaFold Protein Prediction Reshapes APAC Research
Biotech's AI Infusion: A Tremendous Opportunity
NRG Therapeutics Secures £50M Series B for ALS, Parkinson's Drugs
NRG Therapeutics secured £50 million in Series B funding, led by SV Health Investors’ Dementia Discovery Fund. This investment will advance mitochondrial-targeting treatments for neurodegenerative diseases. The company aims to transition its pipeline, including lead candidate NRG5051 for ALS and Parkinson's, into...
ArcaScience Secures $7M for AI Drug Development Platform Expansion
The platform transforms biomedical data into actionable benefit-risk insights for drug development.
Mabylon Raises €31.8M to Advance Allergy Antibody Pipeline
Mabylon, a Swiss biotech, secured €31.8 million in new funding. This investment will advance its lead peanut allergy program and early-stage pipeline. The funding came from existing private investors, including former Roche management and board members.
Mabylon Raises €31.8M to Advance Allergy Antibody Pipeline
Zurich-based Mabylon , a Swiss biotech scale-up, secured €31.8 million in new funding. This Mabylon funding round will advance its lead peanut allergy program.
ASTRA Therapeutics Raises €8.3M for Precision Animal Parasiticides
Villigen, Switzerland-based ASTRA Therapeutics raised €8.3 million in a Seed funding round.
ASTRA Therapeutics Raises €8.3M for Precision Animal Parasiticides
Villigen, Switzerland-based ASTRA Therapeutics raised €8.3 million in a Seed funding round.
Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform
Upstream Bio IPOs at $830M Valuation, Raises $255M, Advances Respiratory Treatments
